Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets, CFDs, OTC options or any of our other products work and whether you can afford to take the high risk of losing your money.

Vir Biotechnology Inc
(NASDAQ:VIR) share price

Add to watchlist
0
0pts
0%
1D
3D
1W
1M
3M
1Y
Interval 30 min

Pricing is indicative. Past performance is not a reliable indicator of future results.

Discover our trading platforms
1 Hour
-
Day
-
7 Day
-
30 Day
-
CLIENT SENTIMENT
83% long

About Vir Biotechnology Inc

Vir Biotechnology is a US healthcare company focusing on clinical-stage immunology. Founded in 2016 with headquarters in San Francisco, it’s dedicated to creating a world without infectious disease using its cutting-edge technologies. The company’s process is to first identify limitations of a patient’s immune system for combatting a particular pathogen, and when it has detected the vulnerabilities of the pathogen, it can then apply technologies using its antibody platform that will lead to effective treatment. Diseases that Vir has treated include Hepatitis B, Covid-19, influenza and HIV/AIDS. Vir Biotechnology stock is listed on the Nasdaq exchange. Start spread betting or trading CFDs on our Vir Biotechnology share price.

Why 1 million+ global traders and investors* choose CMC1

  • Access to 12,000 financial instruments

  • Lightning-fast execution2

  • 99.95%+ platform stability**

  • 99.9% fill rate with 0.0029s execution*

  • Tax-free profits on spread bets; no stamp duty on CFDs4

Trading details

minimum spread
N/A
minimum size (new)
0.001
Shorting allowed
Yes
GSLO allowed
No

Holding costs

Daily - Sell
0.00
Daily - Buy
0.00
Yearly - Sell
0.00
Yearly - Buy
0.00

Margin rates

Tier Units Rates

Trading hours

(shown in London local time )

Related instruments